Exploring the association between statins use or HMG-CoA reductase inhibition and migraine: a systematic review and meta-analysis
Abstract Background Statins or 3‑hydroxy‑3‑methyl‑glutarylcoenzyme A (HMG‑CoA) reductase inhibitors are medications that act by reducing the cholesterol content of liver cells Moreover, statins have been found to improve endothelial function and reduce vascular wall inflammation. A growing body of r...
Saved in:
Main Authors: | Hamdy A. Makhlouf, Amr K. Hassan, Nereen A. Almosilhy, Ahmed S.A. Osman, Shrouk Ramadan, Moaz Elsayed Abouelmagd |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | The Journal of Headache and Pain |
Subjects: | |
Online Access: | https://doi.org/10.1186/s10194-025-01957-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epidemiology of clinically significant migraine in Israel: a retrospective database study
by: A. Shifrin, et al.
Published: (2025-02-01) -
Shift from chronic to episodic migraine frequency in a long-term phase 3 study of galcanezumab
by: Hans-Christoph Diener, et al.
Published: (2025-02-01) -
Effect of combined oral contraceptives on menstrual migraine frequency and severity: a narrative review
by: Yethindra Vityala, et al.
Published: (2024-09-01) -
Evaluation of pediatric migraine triggers: a single-center study
by: Hey-Joon Son, et al.
Published: (2025-02-01) -
Investigating risk factors for migraine in Syrian women: a cross-sectional case-control study
by: Nafiza Martini, et al.
Published: (2025-02-01)